This multiple award IDV was issued by the Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh to procure adult flu vaccines for 2023-2024. Astrazeneca Pharmaceuticals LP is the prime contractor tasked with delivering vaccines under associated task orders or price lists up to a potential value of $8.5 million by February 2024.
The CDC aims to prevent the spread of influenza through this IDV. As the leading public health agency, it coordinates the purchase and distribution of flu vaccines to healthcare providers nationwide. By awarding to multiple vendors, the CDC ensures an adequate supply while encouraging competitive pricing to taxpayers. Task orders will likely specify vaccine types in unit doses, delivery schedules by location, and other terms to efficiently fulfill each flu season's needs. Given its focus on disease control, the CDC relies on contracts like this to carry out its mission and protect public health.
Generated 1/5/24, 1:35 AM